JP2015500293A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500293A5
JP2015500293A5 JP2014546080A JP2014546080A JP2015500293A5 JP 2015500293 A5 JP2015500293 A5 JP 2015500293A5 JP 2014546080 A JP2014546080 A JP 2014546080A JP 2014546080 A JP2014546080 A JP 2014546080A JP 2015500293 A5 JP2015500293 A5 JP 2015500293A5
Authority
JP
Japan
Prior art keywords
neuropeptide
receptor antagonist
pharmaceutical composition
aryl
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014546080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015500293A (ja
JP6381445B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/068257 external-priority patent/WO2013086200A1/en
Publication of JP2015500293A publication Critical patent/JP2015500293A/ja
Publication of JP2015500293A5 publication Critical patent/JP2015500293A5/ja
Application granted granted Critical
Publication of JP6381445B2 publication Critical patent/JP6381445B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014546080A 2011-12-08 2012-12-06 ニューロペプチドsレセプター(npsr)アンタゴニストの組成物および方法 Active JP6381445B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161568540P 2011-12-08 2011-12-08
US61/568,540 2011-12-08
PCT/US2012/068257 WO2013086200A1 (en) 2011-12-08 2012-12-06 Composition and method for neuropeptide s receptor (npsr) antagonists

Publications (3)

Publication Number Publication Date
JP2015500293A JP2015500293A (ja) 2015-01-05
JP2015500293A5 true JP2015500293A5 (cg-RX-API-DMAC7.html) 2015-12-24
JP6381445B2 JP6381445B2 (ja) 2018-08-29

Family

ID=48574884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014546080A Active JP6381445B2 (ja) 2011-12-08 2012-12-06 ニューロペプチドsレセプター(npsr)アンタゴニストの組成物および方法

Country Status (7)

Country Link
US (1) US9150582B2 (cg-RX-API-DMAC7.html)
EP (1) EP2788359B1 (cg-RX-API-DMAC7.html)
JP (1) JP6381445B2 (cg-RX-API-DMAC7.html)
AU (1) AU2012347758B2 (cg-RX-API-DMAC7.html)
CA (1) CA2858571C (cg-RX-API-DMAC7.html)
ES (1) ES2624853T3 (cg-RX-API-DMAC7.html)
WO (1) WO2013086200A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017246706B2 (en) * 2016-04-04 2020-09-17 Research Triangle Institute Neuropeptide s receptor (NPSR) agonists
JOP20190060A1 (ar) * 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4917489B1 (cg-RX-API-DMAC7.html) * 1970-01-22 1974-05-01
EP0140833B1 (de) * 1983-09-15 1988-03-02 Ciba-Geigy Ag 5-und 6-Azaphthalide, ihre Isomerengemische, Verfahren zu ihrer Herstellung und ihre Verwendung in druck- und wärmeempfindlichen Aufzeichnungsmaterialien
EP0558521A1 (en) * 1990-11-22 1993-09-08 Janssen Pharmaceutica N.V. Isonicotinic acid derivatives and related spiro compounds with herbicidal action
EP1329508B1 (en) 2000-10-13 2010-09-08 Takeda Pharmaceutical Company Limited Novel g protein-coupled receptor protein and dna thereof
US6642255B2 (en) * 2001-01-11 2003-11-04 Bristol-Myers Squibb Pharma Company 1,2,-Disubstituted cyclic inhibitors of matrix metalloproteases and TNF-alpha
US9012407B2 (en) * 2004-04-23 2015-04-21 The Regents Of The University Of California Therapies which act on neuropeptide S receptors
EP2365748A4 (en) * 2008-11-13 2012-05-02 Merck Sharp & Dohme IMIDAZOISOINDOL neuropeptide S RECEPTOR ANTAGONISTS
EP2365749A4 (en) * 2008-11-13 2012-05-30 Merck Sharp & Dohme Quinolone NEURO PEPTIDE-S-Receptor Antagonists

Similar Documents

Publication Publication Date Title
TWI404721B (zh) 胺基-雜環化合物
KR100197454B1 (ko) 디아자비시클릭 뉴로키닌 길항제
JP2006523193A5 (cg-RX-API-DMAC7.html)
US5739145A (en) Antitussive agents
TW200427690A (en) Opioid and opioid-like compounds and uses thereof
JP2011500638A5 (cg-RX-API-DMAC7.html)
KR20170131650A (ko) 글루타미나제 억제제의 투여 방법
JP5421108B2 (ja) 2−フェノキシピリミジノン類縁体
RU2264401C3 (ru) Производные хинуклидина, способ их получения, фармацевтическая композиция, способ лечения и промежуточные вещества
RU2014123434A (ru) Фармацевтические соединения
JP2005534626A5 (cg-RX-API-DMAC7.html)
TW201022265A (en) Cycloalkane[b]azaindole antagonists of prostaglandin D2 receptors
JP2013231086A (ja) 化学療法の強化方法
ZA200302918B (en) Combination use of acetylcholinesterase inhibitors and gabaa inverse agonists for the treatment of cognitive disorders.
JP2004529105A5 (cg-RX-API-DMAC7.html)
JP2009538873A5 (cg-RX-API-DMAC7.html)
JP2004531531A5 (cg-RX-API-DMAC7.html)
US20130158035A1 (en) Antimetastatic compounds
JP2006522128A5 (cg-RX-API-DMAC7.html)
WO2005102388A1 (ja) 新規なblt2介在性疾患、blt2結合剤および化合物
CN1938028A (zh) 止痒剂
WO2015002755A2 (en) Compounds for the treatment of malaria
CZ285481B6 (cs) 6-(2-imidazolinylamino)chinolinové sloučeniny použitelné jako alfa-2-adrenoceptorové agonisté
JPH10502657A (ja) ヘテロ環縮合モルヒノイド誘導体
US20090286862A1 (en) Therapeutic agent for psychoneurotic disease